Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
6.75
0.00 (0.00%)
Oct 17, 2025, 4:00 PM EDT - Market closed
Kamada Market Cap
Kamada has a market cap or net worth of $379.90 million as of October 17, 2025. Its market cap has increased by 26.38% in one year.
Market Cap
379.90M
Enterprise Value
324.18M
1-Year Change
26.38%
Ranking
Category
Stock Price
$6.75
Market Cap Chart
Since May 31, 2013, Kamada's market cap has increased from $346.50M to $379.90M, an increase of 9.64%. That is a compound annual growth rate of 0.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 388.20M | 10.88% |
| Dec 31, 2024 | 350.10M | 27.59% |
| Dec 29, 2023 | 274.40M | 52.78% |
| Dec 30, 2022 | 179.60M | -38.99% |
| Dec 31, 2021 | 294.40M | 12.58% |
| Dec 31, 2020 | 261.50M | -4.98% |
| Dec 31, 2019 | 275.20M | 36.71% |
| Dec 31, 2018 | 201.30M | 16.29% |
| Dec 29, 2017 | 173.10M | -12.80% |
| Dec 30, 2016 | 198.50M | 33.04% |
| Dec 31, 2015 | 149.20M | 9.22% |
| Dec 31, 2014 | 136.60M | -73.22% |
| Dec 31, 2013 | 510.10M | 47.22% |
| May 31, 2013 | 346.50M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |